MAGRILAN is a new antidepressant with a different molecule to all existing antidepressants.
In animal studies Fluoxetine showed to exert directly on nonadrenergic and dopaminergic receptors.
The exerted activity is probably due to the selective inhibition of the serotonin intake in the presynaptic neurons.